Hormonal dysfunction in adult patients affected with inherited metabolic disorders

1Vantyghem MC, Dobbelaere D, Mention K, Wemeau JL, Saudubray JM, Douillard C. Endocrine manifestations related to inherited metabolic diseases in adults. Orphanet J Rare Dis. 2012;7:11. doi: 10.1186/1750-1172-7-11 Vantyghem MC Dobbelaere D Mention K Wemeau JL Saudubray JM Douillard C Endocrine manifestations related to inherited metabolic diseases in adults Orphanet J Rare Dis 2012711 10.1186/1750-1172-7-11334954422284844Open DOISearch in Google Scholar

2Sanderson S, Green A, Preece MA, Burton H. The incidence of inherited metabolic disorders in the West Midlands, UK. Arch Dis Child. 2006;91(11):896–9. doi: 10.1136/adc.2005.091637 Sanderson S Green A Preece MA Burton H The incidence of inherited metabolic disorders in the West Midlands, UK Arch Dis Child 200691118969 10.1136/adc.2005.091637208293416690699Open DOISearch in Google Scholar

3Stępień KM, Hendriksz CJ. The principles of the transition process from paediatric to adult services in inborn errors of metabolism – own experience. Dev Period Med. 2015;19(4):523–7. StępieńKM HendrikszCJ The principles of the transition process from paediatric to adult services in inborn errors of metabolism – own experience Dev Period Med 20151945237Search in Google Scholar

4McDermott JH, Walsh CH. Hypogonadism in hereditary hemo-chromatosis. J Clin Endocrinol Metab. 2005;90(4):2451–5. doi: 10.1210/jc.2004-0980 McDermott JH Walsh CH. Hypogonadism in hereditary hemo-chromatosis J Clin Endocrinol Metab 200590424515 10.1210/jc.2004-098015657376Open DOISearch in Google Scholar

5Buretić-Tomljanović A, Vlastelić I, Radojcić Badovinac A, Starcević-Cizmarević N, Nadalin S, Ristić S. The impact of hemo-chromatosis mutations and transferrin genotype on gonadotropin serum levels in infertile men. Fertil Steril. 2009;91(5):1793–800. doi: 10.1016/j.fertnstert.2008.02.129 Buretić-TomljanovićA VlastelićI Radojcić BadovinacA Starcević-CizmarevićN NadalinS RistićS The impact of hemo-chromatosis mutations and transferrin genotype on gonadotropin serum levels in infertile men Fertil Steril 20099151793800 10.1016/j.fertnstert.2008.02.12918395717Open DOISearch in Google Scholar

6Giannitrapani L, Soresi M, La Spada E, Cervello M, D’Alessandro N, Montalto G. Sex hormones and risk of liver tumor. Ann N Y Acad Sci. 2006;1089:228–36. doi: 10.1196/annals.1386.044 Giannitrapani L Soresi M La SpadaE CervelloM D’AlessandroN MontaltoG Sex hormones and risk of liver tumor Ann N Y Acad Sci 2006108922836 10.1196/annals.1386.04417261770Open DOISearch in Google Scholar

7Wang Y, Busin R, Reeves C, Bezman L, Raymond G, Toomer CJ, et al. X-linked adrenoleukodystrophy: ABCD1 de novo mutations and mosaicism. Mol Genet Metab. 2011;104(1–2):160–6. doi: 10.1016/j.ymgme.2011.05.016 Wang Y Busin R Reeves C Bezman L Raymond G Toomer CJ et al X-linked adrenoleukodystrophy: ABCD1 de novo mutations and mosaicism Mol Genet Metab 20111041–21606 10.1016/j.ymgme.2011.05.01621700483Open DOISearch in Google Scholar

8Polgreen LE, Chahla S, Miller W, Rothman S, Tolar J, Kivisto T, et al. Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison’s disease improves survival and neurological outcomes. Eur J Pediatr. 2011;170(8):1049–54. doi: 10.1007/s00431-011-1401-1 Polgreen LE Chahla S Miller W Rothman S Tolar J Kivisto T et al Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison’s disease improves survival and neurological outcomes Eur J Pediatr 20111708104954 10.1007/s00431-011-1401-1310127821279382Open DOISearch in Google Scholar

9Assies J, Gooren LJ, Van Geel B, Barth PG. Signs of testicular insufficiency in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy: a retrospective study. Int J Androl. 1997;20(5):315–21. doi: 10.1046/j.1365-2605.1997.00066.x Assies J Gooren LJ Van GeelB BarthPG Signs of testicular insufficiency in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy: a retrospective study Int J Androl 199720531521 10.1046/j.1365-2605.1997.00066.x16130276Open DOISearch in Google Scholar

10Aversa A, Palleschi S, Cruccu G, Silvestroni L, Isidori A, Fabbri A. Rapid decline of fertility in a case of adrenoleukodystrophy. Hum Reprod. 1998;13(9):2474–9. doi: 10.1093/humrep/13.9.2474 Aversa A Palleschi S Cruccu G Silvestroni L Isidori A Fabbri A Rapid decline of fertility in a case of adrenoleukodystrophy Hum Reprod 199813924749 10.1093/humrep/13.9.24749806270Open DOISearch in Google Scholar

11López-Erauskin J, Fourcade S, Galino J, Ruiz M, Schlüter A, Naudi A, et al. Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy. Ann Neurol. 2011;70(1):84–92. doi: 10.1002/ana.22363 López-Erauskin J Fourcade S Galino J Ruiz M Schlüter A Naudi A et al Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy Ann Neurol 20117018492 10.1002/ana.22363322984321786300Open DOISearch in Google Scholar

12Jaeken J. Congenital disorders of glycosylation (CDG): it’s (nearly) all in it! J Inherit Metab Dis. 2011;34(4):853–8. doi: 10.1007/s10545-011-9299-3 Jaeken J Congenital disorders of glycosylation (CDG): it’s (nearly) all in it! J Inherit Metab Dis 20113448538 10.1007/s10545-011-9299-321384229Open DOISearch in Google Scholar

13de Zegher F, Jaeken J. Endocrinology of the carbohydrate-deficient glycoprotein syndrome type 1 from birth through adolescence. Pediatr Res. 1995;37(4 Pt 1):395–401. doi: 10.1203/00006450-199504000-00003 de ZegherF JaekenJ Endocrinology of the carbohydrate-deficient glycoprotein syndrome type 1 from birth through adolescence Pediatr Res 1995374 Pt 1395401 10.1203/00006450-199504000-000037596677Open DOISearch in Google Scholar

14Kristiansson B, Stibler H, Wide L. Gonadal function and glycoprotein hormones in the carbohydrate-deficient glycoprotein (CDG) syndrome. Acta Paediatr. 1995;84(6):655–9. doi: 10.1111/j.1651- 2227.1995.tb13720.x Kristiansson B Stibler H Wide L Gonadal function and glycoprotein hormones in the carbohydrate-deficient glycoprotein (CDG) syndrome Acta Paediatr 19958466559 10.1111/j.1651-2227.1995.tb13720.x7670249Open DOISearch in Google Scholar

15Miller BS, Freeze HH, Hofmann GF, Sarafoglou K. Pubertal development in ALG6 deficiency (congenital disorder of glycosylation type Ic). Mol Genet Metab. 2011;103(1):101–3. doi: 10.1016/j.ymgme.2011.01.016 Miller BS Freeze HH Hofmann GF Sarafoglou K Pubertal development in ALG6 deficiency (congenital disorder of glycosylation type Ic) Mol Genet Metab 201110311013 10.1016/j.ymgme.2011.01.016386939721334936Open DOISearch in Google Scholar

16Shanti B, Silink M, Bhattacharya K, Howard NJ, Carpenter K, Fietz M, et al. Congenital disorder of glycosylation type Ia: heterogeneity in the clinical presentation from multivisceral failure to hyperinsulinaemic hypoglycaemia as leading symptoms in three infants with phosphomannomutase deficiency. J Inherit Metab Dis. 2009;32(Suppl 1):S241–51. doi: 10.1007/s10545-009-1180-2 Shanti B Silink M Bhattacharya K Howard NJ Carpenter K Fietz M et al Congenital disorder of glycosylation type Ia: heterogeneity in the clinical presentation from multivisceral failure to hyperinsulinaemic hypoglycaemia as leading symptoms in three infants with phosphomannomutase deficiency J Inherit Metab Dis 200932Suppl 1S24151 10.1007/s10545-009-1180-219396570Open DOISearch in Google Scholar

17Chang IJ, He M, Lam CT. Congenital disorders of glycosylation. Ann Transl Med. 2018;6(24):477. doi: 10.21037/atm.2018.10.45 Chang IJ He M Lam CT Congenital disorders of glycosylation Ann Transl Med 2018624477 10.21037/atm.2018.10.45633136530740408Open DOISearch in Google Scholar

18Rubio-Gozalbo ME, Gubbels CS, Bakker JA, Menheere PP, Wodzig WK, Land JA. Gonadal function in male and female patients with classic galactosemia. Hum Reprod Update. 2010;16(2):177–88. doi: 10.1093/humupd/dmp038 Rubio-Gozalbo ME GubbelsCS BakkerJA MenheerePP WodzigWK LandJA Gonadal function in male and female patients with classic galactosemia Hum Reprod Update 201016217788 10.1093/humupd/dmp03819793842Open DOISearch in Google Scholar

19Rubio-Gozalbo ME, Haskovic M, Bosch AM, Burnyte B, Coelho AI, Cassiman D, et al. The natural history of classic galacto-semia: lessons from the GalNet registry. Orphanet J Rare Dis. 2019;14(1):86. doi: 10.1186/s13023-019-1047-z Rubio-Gozalbo ME Haskovic M Bosch AM Burnyte B Coelho AI Cassiman D et al The natural history of classic galacto-semia: lessons from the GalNet registry Orphanet J Rare Dis 201914186 10.1186/s13023-019-1047-z648699631029175Open DOISearch in Google Scholar

20Demirbas D, Coelho AI, Rubio-Gozalbo ME, Berry GT. Hereditary galactosemia. Metabolism. 2018;83:188–96. doi: 10.1016/j. metabol.2018.01.025 Demirbas D Coelho AI Rubio-Gozalbo ME Berry GT Hereditary galactosemia Metabolism 20188318896 10.1016/j.metabol.2018.01.02529409891Open DOISearch in Google Scholar

21Colhoun HO, Rubio Gozalbo EM, Bosch AM, Knerr I, Dawson C, Brady J, et al. Fertility in classical galactosaemia, a study of N-glycan, hormonal and inflammatory gene interactions. Orphanet J Rare Dis. 2018;13(1):164. doi: 10.1186/s13023-018-0906-3 Colhoun HO Rubio Gozalbo EM Bosch AM Knerr I Dawson C Brady J et al Fertility in classical galactosaemia, a study of N-glycan, hormonal and inflammatory gene interactions Orphanet J Rare Dis 2018131164 10.1186/s13023-018-0906-3614652430231941Open DOISearch in Google Scholar

22Thakur M, Feldman G, Puscheck EE. Primary ovarian insufficiency in classic galactosemia: current understanding and future research opportunities. J Assist Reprod Genet. 2018;35(1):3–16. doi: 10.1007/s10815-017-1039-7 Thakur M Feldman G Puscheck EE Primary ovarian insufficiency in classic galactosemia: current understanding and future research opportunities J Assist Reprod Genet 2018351316 10.1007/s10815-017-1039-7575846228932969Open DOISearch in Google Scholar

23Fridovich-Keil J, Walter J. Galactosaemia. In: Valle D, editor. The online metabolic and molecular bases of inherited disease, OM-MBID. New York, New York, USA: The McGrawHill Companies, Inc; 2008. Fridovich-Keil J WalterJ Galactosaemia ValleD The online metabolic and molecular bases of inherited disease, OM-MBID New York, New York, USA The McGrawHill Companies, Inc 2008Search in Google Scholar

24Gubbels CS, Welt CK, Dumoulin JC, Robben SG, Gordon CM, Dunselman GA, et al. The male reproductive system in classic galactosemia: cryptorchidism and low semen volume. J Inherit Metab Dis. 2013;36(5):779–86. doi: 10.1007/s10545-012-9539-1 Gubbels CS Welt CK Dumoulin JC Robben SG Gordon CM Dunselman GA et al The male reproductive system in classic galactosemia: cryptorchidism and low semen volume J Inherit Metab Dis 201336577986 10.1007/s10545-012-9539-123053469Open DOISearch in Google Scholar

25Kelley RI, Hennekam RC. The Smith-Lemli-opitz syndrome. J Med Genet. 2000;37(5):321–35. doi: 10.1136/jmg.37.5.321. Kelley RI Hennekam RC The Smith-Lemli-opitz syndrome J Med Genet 200037532135 10.1136/jmg.37.5.321173457310807690Open DOISearch in Google Scholar

26Wasserstein MP, Larkin AE, Glass RB, Schuchman EH, Desnick RJ, McGovern MM. Growth restriction in children with type B Niemann-Pick disease. J Pediatr. 2003;142(4):424–8. doi: 10.1067/mpd.2003.113 Wasserstein MP Larkin AE Glass RB Schuchman EH Desnick RJ McGovern MM Growth restriction in children with type B Niemann-Pick disease J Pediatr 200314244248 10.1067/mpd.2003.11312712061Open DOISearch in Google Scholar

27Winkler L, Offner G, Krull F, Brodehl J. Growth and pubertal development in nephropathic cystinosis. Eur J Pediatr. 1993;152(3):244–9. doi: 10.1007/BF01956154 Winkler L Offner G Krull F Brodehl J Growth and pubertal development in nephropathic cystinosis Eur J Pediatr 199315232449 10.1007/BF019561548444253Open DOISearch in Google Scholar

28Sansanwal P, Li L, Hsieh SC, Sarwal MM. Insights into novel cellular injury mechanisms by gene expression profiling in nephropathic cystinosis. J Inherit Metab Dis. 2010;33(6):775–86. doi: 10.1007/s10545-010-9203-6 Sansanwal P Li L Hsieh SC Sarwal MM Insights into novel cellular injury mechanisms by gene expression profiling in nephropathic cystinosis J Inherit Metab Dis 201033677586 10.1007/s10545-010-9203-620865335Open DOISearch in Google Scholar

29Elmonem MA, Veys KR, Soliman NA, van Dyck M, van den Heuvel LP, Levtchenko E. Cystinosis: a review. Orphanet J Rare Dis. 2016;11:47. doi: 10.1186/s13023-016-0426-y Elmonem MA Veys KR Soliman NA van DyckM van den HeuvelLP LevtchenkoE Cystinosis: a review Orphanet J Rare Dis 20161147 10.1186/s13023-016-0426-y484106127102039Open DOISearch in Google Scholar

30Besouw MT, Kremer JA, Janssen MC, Levtchenko EN. Fertility status in male cystinosis patients treated with cysteamine. Fertil Steril. 2010;93(6):1880–3. doi: 10.1016/j.fertnstert.2008.12.113 Besouw MT Kremer JA Janssen MC Levtchenko EN Fertility status in male cystinosis patients treated with cysteamine Fertil Steril 201093618803 10.1016/j.fertnstert.2008.12.11319217094Open DOISearch in Google Scholar

31Reiss RE, Kuwabara T, Smith ML, Gahl WA. Successful pregnancy despite placental cystine crystals in a woman with nephropathic cystinosis. N Engl J Med. 1988;319(4):223–6. doi: 10.1056/NEJM198807283190406 Reiss RE Kuwabara T Smith ML Gahl WA Successful pregnancy despite placental cystine crystals in a woman with nephropathic cystinosis N Engl J Med 198831942236 10.1056/NEJM1988072831904063292915Open DOISearch in Google Scholar

32Faggiano A, Pisani A, Milone F, Gaccione M, Filippella M, Santoro A, et al. Endocrine dysfunction in patients with Fabry disease. J Clin Endocrinol Metab. 2006;91(11):4319–25. doi: 10.1210/jc.2006-0858 Faggiano A Pisani A Milone F Gaccione M Filippella M Santoro A et al Endocrine dysfunction in patients with Fabry disease J Clin Endocrinol Metab 20069111431925 10.1210/jc.2006-085816926253Open DOISearch in Google Scholar

33Lacombe D, Germain DP, Papaxanthos-Roche A. Azoospermie: un nouveau signe d’appel de la maladie de Fabry [Azoospermia as a new feature of Fabry disease]. Rev Med Interne. 2010;31(Suppl 2):S214–6. French. doi: 10.1016/S0248-8663(10)70014-X Lacombe D Germain DP Papaxanthos-Roche A Azoospermie: un nouveau signe d’appel de la maladie de Fabry [Azoospermia as a new feature of Fabry disease] Rev Med Interne 201031Suppl 2S2146 10.1016/S0248-8663(10)70014-XOpen DOISearch in Google Scholar

34Amicus Therapeutics. Galafold™ (migalastat) capsules, for oral use: US prescribing information; 2018. Available from: https://www.fda.gov/ Accessed 29 Nov 2019. Amicus Therapeutics. Galafold™ (migalastat) capsules, for oral use: US prescribing information 2018 Available from https://www.fda.gov/ Accessed 29 Nov 2019Search in Google Scholar

35Chow J, Rahman J, Achermann JC, Dattani MT, Rahman S. Mitochondrial disease and endocrine dysfunction. Nat Rev Endocrinol. 2017;13(2):92–104. doi: 10.1038/nrendo.2016.151 Chow J Rahman J Achermann JC Dattani MT Rahman S Mitochondrial disease and endocrine dysfunction Nat Rev Endocrinol 201713292104 10.1038/nrendo.2016.15127716753Open DOISearch in Google Scholar

36Pierce SB, Chisholm KM, Lynch ED, Lee MK, Walsh T, Opitz JM, et al. Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome. Proc Natl Acad Sci USA. 2011;108(16):6543–8. doi: 10.1073/pnas.1103471108 Pierce SB Chisholm KM Lynch ED Lee MK Walsh T Opitz JM et al Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome Proc Natl Acad Sci USA 20111081665438 10.1073/pnas.1103471108308102321464306Open DOISearch in Google Scholar

37Gironi M, Lamperti C, Nemni R, Moggio M, Comi G, Guerini FR, et al. Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency. Neurology. 2004;62(5):818–20. doi: 10.1212/01.wnl.0000113719.67643.b7 Gironi M Lamperti C Nemni R Moggio M Comi G Guerini FR et al Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency Neurology 200462581820 10.1212/01.wnl.0000113719.67643.b715007142Open DOISearch in Google Scholar

38Carod-Artal FJ, Herrero MD, Lara MC, López-Gallardo E, Ruiz-Pesini E, Martí R, et al. Cognitive dysfunction and hypogonadotrophic hypogonadism in a Brazilian patient with mitochondrial neurogastrointestinal encephalomyopathy and a novel ECGF1 mutation. Eur J Neurol. 2007;14(5):581–5. doi: 10.1111/j.1468-1331.2007.01720.x Carod-Artal FJ Herrero MD Lara MC López-Gallardo E Ruiz-Pesini E Martí R et al Cognitive dysfunction and hypogonadotrophic hypogonadism in a Brazilian patient with mitochondrial neurogastrointestinal encephalomyopathy and a novel ECGF1 mutation Eur J Neurol 20071455815 10.1111/j.1468-1331.2007.01720.x17437622Open DOISearch in Google Scholar

39Harvey JN, Barnett D. Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol (Oxf). 1992;37(1):97–103. doi: 10.1111/j.1365-2265.1992.tb02289.x Harvey JN Barnett D Endocrine dysfunction in Kearns-Sayre syndrome Clin Endocrinol (Oxf) 199237197103 10.1111/j.1365-2265.1992.tb02289.x1424198Open DOISearch in Google Scholar

40Rangwala SM, Wang X, Calvo JA, Lindsley L, Zhang Y, Deyneko G, et al. Estrogen-related receptor gamma is a key regulator of muscle mitochondrial activity and oxidative capacity. J Biol Chem. 2010;285(29):22619–29. doi: 10.1074/jbc.M110.125401 Rangwala SM Wang X Calvo JA Lindsley L Zhang Y Deyneko G et al Estrogen-related receptor gamma is a key regulator of muscle mitochondrial activity and oxidative capacity J Biol Chem 2010285292261929 10.1074/jbc.M110.125401290338920418374Open DOISearch in Google Scholar

41Lee PJ, Patel A, Hindmarsh PC, Mowat AP, Leonard JV. The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism. Clin Endocrinol (Oxf). 1995;42(6):601–6. doi: 10.1111/j.1365-2265.1995.tb02686.x. Lee PJ Patel A Hindmarsh PC Mowat AP Leonard JV The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism Clin Endocrinol (Oxf) 19954266016 10.1111/j.1365-2265.1995.tb02686.x7634500Open DOISearch in Google Scholar

42Sechi A, Deroma L, Lapolla A, Paci S, Melis D, Burlina A, et al. Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study. J Inherit Metab Dis. 2013;36(1):83–9. doi: 10.1007/s10545-012-9490-1 Sechi A Deroma L Lapolla A Paci S Melis D Burlina A et al Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study J Inherit Metab Dis 2013361839 10.1007/s10545-012-9490-122562700Open DOISearch in Google Scholar

43Panis B, Gerver WJ, Rubio-Gozalbo ME. Growth in treated classical galactosemia patients. Eur J Pediatr. 2007;166(5):443–6. doi: 10.1007/s00431-006-0255-4 Panis B Gerver WJ Rubio-Gozalbo ME Growth in treated classical galactosemia patients Eur J Pediatr 200716654436 10.1007/s00431-006-0255-417024348Open DOISearch in Google Scholar

44Polgreen LE, Miller BS. Growth patterns and the use of growth hormone in the mucopolysaccharidoses. J Pediatr Rehabil Med. 2010;3(1):25–38. doi: 10.3233/PRM-2010-0106 Polgreen LE Miller BS Growth patterns and the use of growth hormone in the mucopolysaccharidoses J Pediatr Rehabil Med 2010312538 10.3233/PRM-2010-0106Open DOISearch in Google Scholar

45Strisciuglio P, Di Maio S, Parenti G, Franzese A, Lubrano P, Mariano A, et al. Evidence of polyglandular involvement in Niemann-Pick disease type B. Eur J Pediatr. 1987;146(4):431–3. doi: 10.1007/BF00444957 Strisciuglio P Di Maio S Parenti G Franzese A Lubrano P Mariano A et al Evidence of polyglandular involvement in Niemann-Pick disease type B Eur J Pediatr 198714644313 10.1007/BF00444957Open DOISearch in Google Scholar

46Cox NR, Morrison NE, Sartin JL, Buonomo FC, Steele B, Baker HJ. Alterations in the growth hormone/insulin-like growth factor I pathways in feline GM1 gangliosidosis. Endocrinology. 1999;140(12):5698–704. doi: 10.1210/endo.140.12.7178 Cox NR Morrison NE Sartin JL Buonomo FC Steele B Baker HJ Alterations in the growth hormone/insulin-like growth factor I pathways in feline GM1 gangliosidosis Endocrinology 1999140125698704 10.1210/endo.140.12.7178Open DOISearch in Google Scholar

47Kaushansky A, Frydman M, Kaufman H, Homburg R. Endocrine studies of the ovulatory disturbances in Wilson’s disease (hepatolenticular degeneration). Fertil Steril. 1987;47(2):270–3. doi: 10.1016/s0015-0282(16)50004-1 Kaushansky A Frydman M Kaufman H Homburg R Endocrine studies of the ovulatory disturbances in Wilson’s disease (hepatolenticular degeneration) Fertil Steril 19874722703 10.1016/s0015-0282(16)50004-1Open DOISearch in Google Scholar

48Tan EY, Boelens JJ, Jones SA, Wynn RF. Hematopoietic stem cell transplantation in inborn errors of metabolism. Front Pediatr. 2019;7:433. doi: 10.3389/fped.2019.00433 Tan EY Boelens JJ Jones SA Wynn RF Hematopoietic stem cell transplantation in inborn errors of metabolism Front Pediatr 20197433 10.3389/fped.2019.00433682429131709204Open DOISearch in Google Scholar

49Todkar K, Ilamathi HS, Germain M. Mitochondria and lysosomes: discovering bonds. Front Cell Dev Biol. 2017;5:106. doi: 10.3389/fcell.2017.00106 Todkar K Ilamathi HS Germain M Mitochondria and lysosomes: discovering bonds Front Cell Dev Biol 20175106 10.3389/fcell.2017.00106572546929270406Open DOISearch in Google Scholar

50Bartelink IH, van Reij EM, Gerhardt CE, van Maarseveen EM, de Wildt A, Versluys B, et al. Fludarabine and exposure-targeted busulfan compares favorably with busulfan/cyclophosphamide-based regimens in pediatric hematopoietic cell transplantation: maintaining efficacy with less toxicity. Biol Blood Marrow Transplant. 2014;20(3):345–53. doi: 10.1016/j.bbmt.2013.11.027 Bartelink IH van Reij EM Gerhardt CE van Maarseveen EM de Wildt A Versluys B et al Fludarabine and exposure-targeted busulfan compares favorably with busulfan/cyclophosphamide-based regimens in pediatric hematopoietic cell transplantation: maintaining efficacy with less toxicity Biol Blood Marrow Transplant 201420334553 10.1016/j.bbmt.2013.11.02724315842Open DOISearch in Google Scholar

51Al-Gadi IS, Haas RH, Falk MJ, Goldstein A, McCormack SE. Endocrine disorders in primary mitochondrial disease. J Endocr Soc. 2018;2(4):361–73. doi: 10.1210/js.2017-00434 Al-Gadi IS HaasRH FalkMJ GoldsteinA McCormackSE Endocrine disorders in primary mitochondrial disease J Endocr Soc 20182436173 10.1210/js.2017-00434586553729594260Open DOISearch in Google Scholar

52Melis D, Pivonello R, Parenti G, Della Casa R, Salerno M, Lombardi G, et al. Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I. J Pediatr. 2007;150(3):300–5, 305.e1. doi: 10.1016/j. jpeds.2006.11.056 Melis D Pivonello R Parenti G Della Casa R Salerno M Lombardi G et al Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I J Pediatr 200715033005 305.e1. doi 10.1016/j.jpeds.2006.11.05617307551Open DOISearch in Google Scholar

53Ön ŞŞ, Acar S, Demir K, Abacı A, Öztürk Y, Kahveci Çelik S, et al. Evaluation of thyroid function tests in children with chronic liver diseases. J Clin Res Pediatr Endocrinol. 2020;12(2):143–9. doi: 10.4274/jcrpe.galenos.2019.2019.0029 ÖnŞŞ AcarS DemirK AbacıA ÖztürkY Kahveci ÇelikS et al Evaluation of thyroid function tests in children with chronic liver diseases J Clin Res Pediatr Endocrinol 20201221439 10.4274/jcrpe.galenos.2019.2019.0029729139631486329Open DOISearch in Google Scholar

54Liang WC, Nishino I. State of the art in muscle lipid diseases. Acta Myol. 2010;29(2):351–6. Liang WC Nishino I State of the art in muscle lipid diseases Acta Myol 20102923516Search in Google Scholar

55Benelli E, Fiore E, Giustarini E, Romani R, Pennisi E, Pinchera A, et al. Clear cells detection in nodular thyroid disease is not always indicative of neoplasia: description of the first case of thyroid involvement in multisystem triglyceride storage disease. Thyroid. 2008;18(9):1001–3. doi: 10.1089/thy.2007.0228 Benelli E Fiore E Giustarini E Romani R Pennisi E Pinchera A et al Clear cells detection in nodular thyroid disease is not always indicative of neoplasia: description of the first case of thyroid involvement in multisystem triglyceride storage disease Thyroid 200818910013 10.1089/thy.2007.022818788920Open DOISearch in Google Scholar

56Laforêt P, Stojkovic T, Bassez G, Carlier PG, Clément K, Wahbi K, et al. Neutral lipid storage disease with myopathy: a whole-body nuclear MRI and metabolic study. Mol Genet Metab. 2013;108(2):125–31. doi: 10.1016/j.ymgme.2012.12.004 Laforêt P Stojkovic T Bassez G Carlier PG Clément K Wahbi K et al Neutral lipid storage disease with myopathy: a whole-body nuclear MRI and metabolic study Mol Genet Metab 2013108212531 10.1016/j.ymgme.2012.12.00423333026Open DOISearch in Google Scholar

57Mohamed M, Theodore M, Claahsen-van der Grinten H, van Herwaarden AE, Huijben K, van Dongen L, et al. Thyroid function in PMM2-CDG: diagnostic approach and proposed management. Mol Genet Metab. 2012;105(4):681–3. doi: 10.1016/j. ymgme.2012.02.001 Mohamed M Theodore M Claahsen-van der Grinten H van Herwaarden AE Huijben K van Dongen L et al Thyroid function in PMM2-CDG: diagnostic approach and proposed management Mol Genet Metab 201210546813 10.1016/j.ymgme.2012.02.00122386715Open DOISearch in Google Scholar

58Gaide Chevronnay HP, Janssens V, Van Der Smissen P, Rocca CJ, Liao XH, Refetoff S, et al. Hematopoietic stem cells transplantation can normalize thyroid function in a cystinosis mouse model. Endocrinology. 2016;157(4):1363–71. doi: 10.1210/en.2015-1762 Gaide Chevronnay HP Janssens V Van Der Smissen P Rocca CJ Liao XH Refetoff S et al Hematopoietic stem cells transplantation can normalize thyroid function in a cystinosis mouse model Endocrinology 20161574136371 10.1210/en.2015-1762481672426812160Open DOISearch in Google Scholar

59Weinhofer I, Kunze M, Forss-Petter S, Berger J. Involvement of human peroxisomes in biosynthesis and signaling of steroid and peptide hormones. Subcell Biochem. 2013;69:101–10. doi: 10.1007/978-94-007-6889-5_6 Weinhofer I Kunze M Forss-Petter S Berger J Involvement of human peroxisomes in biosynthesis and signaling of steroid and peptide hormones Subcell Biochem 20136910110 10.1007/978-94-007-6889-5_623821145Open DOISearch in Google Scholar

60Bruno C, Minetti C, Tang Y, Magalhães PJ, Santorelli FM, Shanske S, et al. Primary adrenal insufficiency in a child with a mitochondrial DNA deletion. J Inherit Metab Dis. 1998;21(2):155–61. doi: 10.1023/a:1005347826664 Bruno C Minetti C Tang Y Magalhães PJ Santorelli FM Shanske S et al Primary adrenal insufficiency in a child with a mitochondrial DNA deletion J Inherit Metab Dis 199821215561 10.1023/a:1005347826664Open DOISearch in Google Scholar

61Boles RG, Roe T, Senadheera D, Mahnovski V, Wong LJ. Mitochondrial DNA deletion with Kearns Sayre syndrome in a child with Addison disease. Eur J Pediatr. 1998;157(8):643–7. doi: 10.1007/s004310050902 Boles RG Roe T Senadheera D Mahnovski V Wong LJ Mitochondrial DNA deletion with Kearns Sayre syndrome in a child with Addison disease Eur J Pediatr 199815786437 10.1007/s0043100509029727847Open DOISearch in Google Scholar

62Hopkins SE, Somoza A, Gilbert DL. Rare autosomal dominant POLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease. J Child Neurol. 2010;25(6):752–6. doi: 10.1177/0883073809343313 Hopkins SE Somoza A Gilbert DL Rare autosomal dominant POLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease J Child Neurol 20102567526 10.1177/088307380934331319815814Open DOISearch in Google Scholar

63Shimizu J, Inatsu A, Oshima S, Shimizu E, Hirata H, Yasuda H, et al. Hyperkalemia in familial mitochondrial cytopathy. Clin Nephrol. 2008;70(4):348–53. doi: 10.5414/cnp70348 Shimizu J Inatsu A Oshima S Shimizu E Hirata H Yasuda H et al Hyperkalemia in familial mitochondrial cytopathy Clin Nephrol 200870434853 10.5414/cnp7034818826862Open DOISearch in Google Scholar

64Watts RW, Harkness RA, Spellacy E, Taylor NF. Lesch-Nyhan syndrome: growth delay, testicular atrophy and a partial failure of the 11 beta-hydroxylation of steroids. J Inherit Metab Dis. 1987;10(3):210–23. doi: 10.1007/BF01800063 Watts RW Harkness RA Spellacy E Taylor NF Lesch-Nyhan syndrome: growth delay, testicular atrophy and a partial failure of the 11 beta-hydroxylation of steroids J Inherit Metab Dis 198710321023 10.1007/BF018000632828760Open DOISearch in Google Scholar

65Bianconi SE, Conley SK, Keil MF, Sinaii N, Rother KI, Porter FD, et al. Adrenal function in Smith-Lemli-Opitz syndrome. Am J Med Genet A. 2011 ;155A(11):2732–8. doi: 10.1002/ajmg.a.34271 Bianconi SE Conley SK Keil MF Sinaii N Rother KI Porter FD et al Adrenal function in Smith-Lemli-Opitz syndrome Am J Med Genet A 2011 155A112732–8 10.1002/ajmg.a.34271348838021990131Open DOISearch in Google Scholar

66Donoghue SE, Pitt JJ, Boneh A, White SM. Smith-Lemli-Opitz syndrome: clinical and biochemical correlates. J Pediatr Endocrinol Metab. 2018;31(4):451–9. doi: 10.1515/jpem-2017-0501 Donoghue SE Pitt JJ Boneh A White SM Smith-Lemli-Opitz syndrome: clinical and biochemical correlates J Pediatr Endocrinol Metab 20183144519 10.1515/jpem-2017-050129455191Open DOISearch in Google Scholar

67Saudubray JM, Sedel F. Les maladies héréditaires du métabolisme à l’âge adulte [Inborn errors of metabolism in adults]. Ann Endocrinol (Paris). 2009;70(1):14–24. French. doi: 10.1016/j.ando.2008.12.004 Saudubray JM Sedel F Les maladies héréditaires du métabolisme à l’âge adulte [Inborn errors of metabolism in adults] Ann Endocrinol (Paris) 20097011424 10.1016/j.ando.2008.12.00419178907Open DOISearch in Google Scholar

68Erdem E, Cayonu N, Uysalol E, Yildirmak ZY. Chronic intermittent form of isovaleric acidemia mimicking diabetic ketoacidosis. J Pediatr Endocrinol Metab. 2010;23(5):503–5. doi: 10.1515/jpem.2010.082 Erdem E Cayonu N Uysalol E Yildirmak ZY Chronic intermittent form of isovaleric acidemia mimicking diabetic ketoacidosis J Pediatr Endocrinol Metab 20102355035 10.1515/jpem.2010.08220662350Open DOISearch in Google Scholar

69Marquard J, El Scheich T, Klee D, Schmitt M, Meissner T, Mayatepek E, et al. Chronic pancreatitis in branched-chain organic acidurias – a case of methylmalonic aciduria and an overview of the literature. Eur J Pediatr. 2011;170(2):241–5. doi: 10.1007/s00431-010-1313-5 Marquard J El Scheich T Klee D Schmitt M Meissner T Mayatepek E et al Chronic pancreatitis in branched-chain organic acidurias – a case of methylmalonic aciduria and an overview of the literature Eur J Pediatr 201117022415 10.1007/s00431-010-1313-520924605Open DOISearch in Google Scholar

70Vantyghem MC, Fajardy I, Dhondt F, Girardot C, D’Herbomez M, Danze PM, et al. Phenotype and HFE genotype in a population with abnormal iron markers recruited from an Endocrinology Department. Eur J Endocrinol. 2006;154(6):835–41. doi: 10.1530/eje.1.02152 Vantyghem MC Fajardy I Dhondt F Girardot C D’Herbomez M Danze PM et al Phenotype and HFE genotype in a population with abnormal iron markers recruited from an Endocrinology Department Eur J Endocrinol 2006154683541 10.1530/eje.1.0215216728543Open DOISearch in Google Scholar

71Ogimoto M, Anzai K, Takenoshita H, Kogawa K, Akehi Y, Yoshida R, et al. Criteria for early identification of aceruloplasminemia. Intern Med. 2011;50(13):1415–8. doi: 10.2169/internalmedicine.50.5108 Ogimoto M Anzai K Takenoshita H Kogawa K Akehi Y Yoshida R et al Criteria for early identification of aceruloplasminemia Intern Med 2011501314158 10.2169/internalmedicine.50.510821720062Open DOISearch in Google Scholar

72Oki Y, Okubo M, Tanaka S, Nakanishi K, Kobayashi T, Murase T. Diabetes mellitus secondary to glycogen storage disease type III. Diabet Med. 2000;17(11):810–2. doi: 10.1046/j.1464-5491.2000.00378.x Oki Y Okubo M Tanaka S Nakanishi K Kobayashi T Murase T Diabetes mellitus secondary to glycogen storage disease type III Diabet Med 200017118102 10.1046/j.1464-5491.2000.00378.x11131107Open DOISearch in Google Scholar

73Ismail H. Glycogen storage disease type III presenting with secondary diabetes and managed with insulin: a case report. Cases J. 2009;2:6891. doi: 10.4076/1757-1627-2-6891 Ismail H Glycogen storage disease type III presenting with secondary diabetes and managed with insulin: a case report Cases J 200926891 10.4076/1757-1627-2-6891274025319829878Open DOISearch in Google Scholar

74Filler G, Amendt P, von Bredow MA, Rohde W, Ehrich JH. Slowly deteriorating insulin secretion and C-peptide production characterizes diabetes mellitus in infantile cystinosis. Eur J Pediatr. 1998;157(9):738–42. doi: 10.1007/s004310050926 Filler G Amendt P von BredowMA RohdeW EhrichJH Slowly deteriorating insulin secretion and C-peptide production characterizes diabetes mellitus in infantile cystinosis Eur J Pediatr 1998157973842 10.1007/s0043100509269776533Open DOISearch in Google Scholar

75Karicheva OZ, Kolesnikova OA, Schirtz T, Vysokikh MY, Mager-Heckel AM, Lombès A, et al. Correction of the consequences of mitochondrial 3243A>G mutation in the MT-TL1 gene causing the MELAS syndrome by tRNA import into mitochondria. Nucleic Acids Res. 2011;39(18):8173–86. doi: 10.1093/nar/gkr546 Karicheva OZ Kolesnikova OA Schirtz T Vysokikh MY Mager-Heckel AM Lombès A et al Correction of the consequences of mitochondrial 3243A>G mutation in the MT-TL1 gene causing the MELAS syndrome by tRNA import into mitochondria Nucleic Acids Res 20113918817386 10.1093/nar/gkr546Open DOISearch in Google Scholar

76Karaa A, Goldstein A. The spectrum of clinical presentation, diagnosis, and management of mitochondrial forms of diabetes. Pediatr Diabetes. 2015;16(1):1–9. doi: 10.1111/pedi.12223 Karaa A Goldstein A The spectrum of clinical presentation, diagnosis, and management of mitochondrial forms of diabetes Pediatr Diabetes 201516119 10.1111/pedi.12223Open DOISearch in Google Scholar

77Laloi-Michelin M, Meas T, Ambonville C, Bellanné-Chantelot C, Beaufils S, Massin P, et al.; Mitochondrial diabetes French Study Group. The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes. J Clin Endocrinol Metab. 2009;94(8):3025–30. doi: 10.1210/jc.2008-2680 Laloi-Michelin M Meas T Ambonville C Bellanné-Chantelot C Beaufils S Massin P et al Mitochondrial diabetes French Study Group. The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes J Clin Endocrinol Metab 2009948302530 10.1210/jc.2008-2680Open DOISearch in Google Scholar

78Lightfoot YL, Chen J, Mathews CE. Role of the mitochondria in immune-mediated apoptotic death of the human pancreatic β cell line βLox5. PLoS One. 2011;6(6):e20617. doi: 10.1371/journal. pone.0020617 Lightfoot YL Chen J Mathews CE Role of the mitochondria in immune-mediated apoptotic death of the human pancreatic β cell line βLox5 PLoS One 201166e20617 10.1371/journal.pone.0020617Open DOISearch in Google Scholar

79Lindroos MM, Majamaa K, Tura A, Mari A, Kalliokoski KK, Taittonen MT, et al. m.3243A>G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive beta-cell dysfunction. Diabetes. 2009;58(3):543–9. doi: 10.2337/db08-0981 Lindroos MM Majamaa K Tura A Mari A Kalliokoski KK Taittonen MT et al m.3243A>G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive beta-cell dysfunction Diabetes 20095835439 10.2337/db08-0981Open DOISearch in Google Scholar

80Moravej H, Altassan R, Jaeken J, Enns GM, Ellaway C, Balasubramaniam S, et al. Hypoglycemia in CDG patients due to PMM2 mutations: follow up on hyperinsulinemic patients. JIMD Rep. 2019;51(1):76–81. doi: 10.1002/jmd2.12085 Moravej H Altassan R Jaeken J Enns GM Ellaway C Balasubramaniam S et al Hypoglycemia in CDG patients due to PMM2 mutations: follow up on hyperinsulinemic patients JIMD Rep 20195117681 10.1002/jmd2.12085Open DOISearch in Google Scholar

81de Lonlay P, Seta N. The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib. Biochim Biophys Acta. 2009;1792(9):841–3. doi:10.1016/j.bbadis.2008.11.012 de LonlayP SetaN The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib Biochim Biophys Acta 2009179298413 10.1016/j.bbadis.2008.11.012Open DOISearch in Google Scholar

82Zeevaert R, Scalais E, Muino Mosquera L, De Meirleir L, De Beaufort C, Witsch M, et al. PGM1 deficiency diagnosed during an endocrine work-up of low IGF-1 mediated growth failure. Acta Clin Belg. 2016;71(6):435–7. doi: 10.1080/17843286.2016.1142043 Zeevaert R Scalais E Muino Mosquera L De Meirleir L De Beaufort C Witsch M et al PGM1 deficiency diagnosed during an endocrine work-up of low IGF-1 mediated growth failure Acta Clin Belg 20167164357 10.1080/17843286.2016.1142043Open DOISearch in Google Scholar

83Marshall JD, Bronson RT, Collin GB, Nordstrom AD, Maffei P, Paisey RB, et al. New Alström syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med. 2005;165(6):675–83. doi: 10.1001/archinte.165.6.675 Marshall JD Bronson RT Collin GB Nordstrom AD Maffei P Paisey RB et al New Alström syndrome phenotypes based on the evaluation of 182 cases Arch Intern Med 2005165667583 10.1001/archinte.165.6.675Open DOISearch in Google Scholar

84Tyni T, Rapola J, Palotie A, Pihko H. Hypoparathyroidism in a patient with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency caused by the G1528C mutation. J Pediatr. 1997;131(5):766–8. doi: 10.1016/s0022-3476(97)70111-2. Tyni T Rapola J Palotie A Pihko H Hypoparathyroidism in a patient with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency caused by the G1528C mutation J Pediatr 199713157668 10.1016/s0022-3476(97)70111-2Open DOISearch in Google Scholar

85Baruteau J, Levade T, Redonnet-Vernhet I, Mesli S, Bloom MC, Broué P. Hypoketotic hypoglycemia with myolysis and hypoparathyroidism: an unusual association in medium chain acyl-CoA desydrogenase deficiency (MCADD). J Pediatr Endocrinol Metab. 2009;22(12):1175–7. doi: 10.1515/jpem.2009.22.12.1175 Baruteau J Levade T Redonnet-Vernhet I Mesli S Bloom MC BrouéP Hypoketotic hypoglycemia with myolysis and hypoparathyroidism: an unusual association in medium chain acyl-CoA desydrogenase deficiency (MCADD) J Pediatr Endocrinol Metab 2009221211757 10.1515/jpem.2009.22.12.117520333879Open DOISearch in Google Scholar

86Gordon RJ, Levine MA. Genetic disorders of parathyroid development and function. Endocrinol Metab Clin North Am. 2018;47(4):809–23. doi: 10.1016/j.ecl.2018.07.007 Gordon RJ Levine MA Genetic disorders of parathyroid development and function Endocrinol Metab Clin North Am 201847480923 10.1016/j.ecl.2018.07.007623398830390815Open DOISearch in Google Scholar

87Thoene JG. A review of the role of enhanced apoptosis in the pathophysiology of cystinosis. Mol Genet Metab. 2007;92(4):292–8. doi: 10.1016/j.ymgme.2007.07.008 Thoene JG A review of the role of enhanced apoptosis in the pathophysiology of cystinosis Mol Genet Metab 20079242928 10.1016/j.ymgme.2007.07.00817728168Open DOISearch in Google Scholar

88Baig NA, Herrine SK, Rubin R. Liver disease and diabetes mellitus. Clin Lab Med. 2001;21(1):193–207. Baig NA Herrine SK Rubin R. Liver diseasediabetes mellitus Clin Lab Med 2001211193207Search in Google Scholar

89Karagiannis A, Harsoulis F. Gonadal dysfunction in systemic diseases. Eur J Endocrinol. 2005;152(4):501–13. doi: 10.1530/eje.1.01886 Karagiannis A Harsoulis F Gonadal dysfunction in systemic diseases Eur J Endocrinol 2005152450113 10.1530/eje.1.0188615817904Open DOISearch in Google Scholar